Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bayo, S.
Right arrow Articles by Meijer, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayo, S.
Right arrow Articles by Meijer, C. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2002;31:202-209
© International Epidemiological Association 2002


Cancer

Risk factors of invasive cervical cancer in Mali

Siné Bayoa, F Xavier Boschb, Silvia de Sanjoséb, Nubia Muñozc, Alba Lucia Combitad, Pierre Coursagetd, Mireia Diazb, Amardou Doloe, Adriaan JC van den Brulef and Chris JM Meijerf

a Institut National de Recherche en Santé Publique, Bamako, Mali.
b Servei d'Epidemiologia i Registre del Cancer, Institut Catala d'Oncologia, Barcelona, Spain.
c International Agency for Research on Cancer, Lyon, France.
d Laboratoire de Virologie Moléculaire, INSERM EMIU 00–10 and USC INRA, Faculté de Pharmacie, Tours, France.
e Hôpital National du Point G, Bamako, Mali.
f University Hospital Vrije Universiteit Department of Pathology, Amsterdam, The Netherlands.

Silvia de Sanjosé, Servei d'Epidemiologia i Registre del Cancer, Institut Catala d'Oncologia, Gran Via Km 2,7 08907 L'Hospitalet de Llobregat, Barcelona, Spain. E-mail: s.sanjose{at}ico.scs.es

Abstract

Background Cervical cancer is the most common cancer in women in Mali and the second commonest cause of cancer mortality.

Methods As part of an international effort to evaluate the role of human papillomavirus (HPV) in the aetiology of cervical cancer, we conducted a hospital-based case-control study in three medical centres in Bamako during 1994–1995. A total of 82 cases (invasive cervical cancer patients) and 97 controls matched to the cases for age were included. Information on risk factors was collected through personal interview. Serum antibodies to HPV 16, 18 and 31 virus like particles (VLP) were detected using ELISA assays. Polymerase chain reaction was used to detect HPV DNA in frozen biopsies of cases.

Results Human papillomavirus 6, 18, 31 VLP were detected in 60.4% of cases and 45.4% of controls (P = 0.03). Overall, HPV DNA was identified in 96.9% of the cervical cancer cases. Risk factors for cervical cancer were parity >10 versus <5 children ([odds ratio] OR = 4.8, 95% CI : 1.5–14.7), never having practised vaginal douching (OR = 17.6, 95% CI : 4.2–74.7), re-using home-made feminine napkins (OR = 45.9, 95% CI : 8.8–238.7) and having a husband with more than two wives (OR = 5.3, 95% CI : 1.3–21.3).

Conclusions These data provide further evidence on the role of HPV in cervical cancer and show that high parity and poor genital hygiene conditions were the main co-factors for cervical cancer in this population with prevalent HPV infection.

Keywords HPV, HPV VLP, Africa, cervical cancer

Accepted 6 July 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
K. Aklimunnessa, M. Mori, M. M. H. Khan, F. Sakauchi, T. Kubo, Y. Fujino, S. Suzuki, S. Tokudome, A. Tamakoshi, and for the JACC Study Group
Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women
Jpn. J. Clin. Oncol., August 1, 2006; 36(8): 511 - 518.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
V. K. Madkan, A. A. Giancola, K. K. Sra, and S. K. Tyring
Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases.
Arch Dermatol, March 1, 2006; 142(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
M Molano, E Weiderpass, H Posso, S A Morre, M Ronderos, S Franceschi, A Arslan, C J L M Meijer, N Munoz, and A J C van den Brule
Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia
Sex. Transm. Inf., December 1, 2003; 79(6): 474 - 478.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J.F. Snijders, C. J.L.M. Meijer, and the International Agency for Research on Cancer Mu
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
N. Engl. J. Med., February 6, 2003; 348(6): 518 - 527.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.